share_log

Needham Maintains Buy on Cardlytics, Raises Price Target to $17

Needham Maintains Buy on Cardlytics, Raises Price Target to $17

Needham维持对Cardlytics的买入,将目标股价上调至17美元
Moomoo 24/7 ·  04/09 07:34

Needham analyst Kyle Peterson maintains Cardlytics (NASDAQ:CDLX) with a Buy and raises the price target from $15 to $17.

尼德姆分析师凯尔·彼得森维持Cardlytics(纳斯达克股票代码:CDLX)的买入并将目标股价从15美元上调至17美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发